CAMBRIDGE, Mass., Jan. 4, 2017 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced that it will present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, California on Wednesday, January 11, 2017, at 3:00 PM Pacific Time.
A live webcast of the presentation will be available in the Investors section of Merrimack's website at investors.merrimack.com. A replay of the webcast will be archived there for two weeks following the presentation.
Any statements in this press release about future expectations, plans and prospects for Merrimack constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended. Actual results may differ materially from those indicated by such forward-looking statements. Merrimack anticipates that subsequent events and developments will cause its views to change. However, while Merrimack may elect to update these forward-looking statements at some point in the future, Merrimack specifically disclaims any obligation to do so.
Geoffrey Grande, CFA
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/merrimack-to-present-at-the-35th-annual-jp-morgan-healthcare-conference-300385700.html
SOURCE Merrimack Pharmaceuticals, Inc.